170 related articles for article (PubMed ID: 22280533)
1. Autoimmune hemolytic anemia and autoimmune thrombocytopenia at diagnosis and during follow-up of Hodgkin lymphoma.
Dimou M; Angelopoulou MK; Pangalis GA; Georgiou G; Kalpadakis C; Pappi V; Tsopra O; Koutsoukos K; Zografos E; Boutsikas G; Moschogianni M; Vardounioti I; Petevi K; Karali V; Kanellopoulos A; Ntalageorgos T; Yiakoumis X; Bartzis V; Bitsani A; Pessach E; Efthimiou A; Korkolopoulou P; Rassidakis G; Kyrtsonis MC; Patsouris E; Meletis J; Panayiotidis P; Vassilakopoulos TP
Leuk Lymphoma; 2012 Aug; 53(8):1481-7. PubMed ID: 22280533
[TBL] [Abstract][Full Text] [Related]
2. The impact of autoimmune cytopenias on the clinical course and survival of Hodgkin lymphoma.
Pinczés LI; Szabó R; Miltényi Z; Illés Á
Int J Hematol; 2021 Feb; 113(2):175-182. PubMed ID: 33057959
[TBL] [Abstract][Full Text] [Related]
3. Autoimmune hemolytic anemia and classical Hodgkin lymphoma: a case report and literature review.
Feng Q; Zak D; Daya R
Clin Adv Hematol Oncol; 2012 Apr; 10(4):270-6. PubMed ID: 22706493
[No Abstract] [Full Text] [Related]
4. [Autoimmune hemolytic anemia and immune thrombocytopenia associated with Hodgkin disease: Retrospective monocentric study].
Caré W; Arnautou P; Segot A; de Charry F; Foissaud V; Bugier S; Cournac JM; Konopacki J; Malfuson JV
Rev Med Interne; 2019 Dec; 40(12):785-790. PubMed ID: 31668883
[TBL] [Abstract][Full Text] [Related]
5. Hodgkin lymphoma presenting with various immunologic abnormalities, including autoimmune hepatitis, Hashimoto's thyroiditis, autoimmune hemolytic anemia, and immune thrombocytopenia.
Saitoh T; Matsushima T; Saito Y; Yamane A; Yokohoma A; Irisawa H; Handa H; Tsukamoto N; Karasawa M; Kojima M; Nojima Y; Murakami H
Clin Lymphoma Myeloma; 2008 Feb; 8(1):62-4. PubMed ID: 18501091
[TBL] [Abstract][Full Text] [Related]
6. Paraneoplastic autoimmune cytopenias in Hodgkin lymphoma.
Lechner K; Chen YA
Leuk Lymphoma; 2010 Mar; 51(3):469-74. PubMed ID: 20141438
[TBL] [Abstract][Full Text] [Related]
7. Cold Agglutinins in Peripheral Blood with Atypical Cells with an Owl-Eye Appearance in Bone Trephine.
Memon AM; Karim F
J Coll Physicians Surg Pak; 2018 Mar; 28(3):S58-S59. PubMed ID: 29482710
[TBL] [Abstract][Full Text] [Related]
8. Early versus late intensification for patients with high-risk Hodgkin lymphoma-3 cycles of intensive chemotherapy plus low-dose lymph node radiation therapy versus 4 cycles of combined doxorubicin, bleomycin, vinblastine, and dacarbazine plus myeloablative chemotherapy with autologous stem cell transplantation: five-year results of a randomized trial on behalf of the GOELAMS Group.
Arakelyan N; Berthou C; Desablens B; de Guibert S; Delwail V; Moles MP; Quittet P; Jais JP; Colonna P; Andrieu JM;
Cancer; 2008 Dec; 113(12):3323-30. PubMed ID: 18988286
[TBL] [Abstract][Full Text] [Related]
9. Long-Term Follow-Up of Contemporary Treatment in Early-Stage Hodgkin Lymphoma: Updated Analyses of the German Hodgkin Study Group HD7, HD8, HD10, and HD11 Trials.
Sasse S; Bröckelmann PJ; Goergen H; Plütschow A; Müller H; Kreissl S; Buerkle C; Borchmann S; Fuchs M; Borchmann P; Diehl V; Engert A
J Clin Oncol; 2017 Jun; 35(18):1999-2007. PubMed ID: 28418763
[TBL] [Abstract][Full Text] [Related]
10. Outcome of patients older than 60 years with classical Hodgkin lymphoma treated with front line ABVD chemotherapy: frequent pulmonary events suggest limiting the use of bleomycin in the elderly.
Stamatoullas A; Brice P; Bouabdallah R; Mareschal S; Camus V; Rahal I; Franchi P; Lanic H; Tilly H
Br J Haematol; 2015 Jul; 170(2):179-84. PubMed ID: 25891777
[TBL] [Abstract][Full Text] [Related]
11. Phase II study of ABV (doxorubicin with increased dose, bleomycin and vinblastine) therapy in newly diagnosed advanced-stage Hodgkin lymphoma: Japan Clinical Oncology Group study (JCOG9705).
Ogura M; Itoh K; Ishizawa K; Kobayashi Y; Tobinai K; Kinoshita T; Hirano M; Ueda R; Shibata T; Nakamura S; Tsukasaki K; Hotta T; Shimoyama M; Morishima Y;
Leuk Lymphoma; 2013 Jan; 54(1):46-52. PubMed ID: 22712838
[TBL] [Abstract][Full Text] [Related]
12. Reduced versus full doses of irradiation after 3 cycles of combined doxorubicin, bleomycin, vinblastine, and dacarbazine in early stage Hodgkin lymphomas: results of a randomized trial.
Arakelyan N; Jais JP; Delwail V; Brière J; Moles-Moreau MP; Sénécal D; Berthou C; Desablens B; Colonna P; Andrieu JM;
Cancer; 2010 Sep; 116(17):4054-62. PubMed ID: 20564152
[TBL] [Abstract][Full Text] [Related]
13. Two cycles of doxorubicin, bleomycin, vinblastine, and dacarbazine plus extended-field radiotherapy is superior to radiotherapy alone in early favorable Hodgkin's lymphoma: final results of the GHSG HD7 trial.
Engert A; Franklin J; Eich HT; Brillant C; Sehlen S; Cartoni C; Herrmann R; Pfreundschuh M; Sieber M; Tesch H; Franke A; Koch P; de Wit M; Paulus U; Hasenclever D; Loeffler M; Müller RP; Müller-Hermelink HK; Dühmke E; Diehl V
J Clin Oncol; 2007 Aug; 25(23):3495-502. PubMed ID: 17606976
[TBL] [Abstract][Full Text] [Related]
14. ABVD in older patients with early-stage Hodgkin lymphoma treated within the German Hodgkin Study Group HD10 and HD11 trials.
Böll B; Görgen H; Fuchs M; Pluetschow A; Eich HT; Bargetzi MJ; Weidmann E; Junghanß C; Greil R; Scherpe A; Schmalz O; Eichenauer DA; von Tresckow B; Rothe A; Diehl V; Engert A; Borchmann P
J Clin Oncol; 2013 Apr; 31(12):1522-9. PubMed ID: 23509310
[TBL] [Abstract][Full Text] [Related]
15. Prognostic factors for advanced-stage human immunodeficiency virus-associated classical Hodgkin lymphoma treated with doxorubicin, bleomycin, vinblastine, and dacarbazine plus combined antiretroviral therapy: a multi-institutional retrospective study.
Castillo JJ; Bower M; Brühlmann J; Novak U; Furrer H; Tanaka PY; Besson C; Montoto S; Cwynarski K; Abramson JS; Dalia S; Bibas M; Connors JM; Furman M; Nguyen ML; Cooley TP; Beltran BE; Collins JA; Vose JM; Xicoy B; Ribera JM;
Cancer; 2015 Feb; 121(3):423-31. PubMed ID: 25251326
[TBL] [Abstract][Full Text] [Related]
16. Doxorubicin, bleomycin, vinblastine and dacarbazine chemotherapy with interferon for advanced stage classic Hodgkin lymphoma: a 10-year follow-up study.
Batty N; Hagemeister FB; Feng L; Romaguera JE; Rodriguez MA; McLaughlin P; Samaniego F; Copeland A; Dabaja BS; Younes A
Leuk Lymphoma; 2012 May; 53(5):801-6. PubMed ID: 22023528
[TBL] [Abstract][Full Text] [Related]
17. Severe autoimmune cytopenias in treatment-naive hepatitis C virus infection: clinical description of 16 cases.
Dufour JF; Pradat P; Ruivard M; Hot A; Dumontet C; Broussolle C; Trepo C; Sève P
Eur J Gastroenterol Hepatol; 2009 Mar; 21(3):245-53. PubMed ID: 19279468
[TBL] [Abstract][Full Text] [Related]
18. Intermediate stage Hodgkin lymphoma in partial remission after three or four courses of doxorubicin, bleomycin, vinblastine dacarbazine: no benefit of one course of intensive chemotherapy before irradiation.
Arakelyan N; Jais JP; Tomowiack C; Colombat P; Berthou C; Desablens B; Moles-Moreau MP; Gastinne T; Quittet P; Casassus P; Le Pourhiet-Le Mevel A; Ghandour C; Brière J; Colonna P; Andrieu JM
Leuk Lymphoma; 2013 Jan; 54(1):76-82. PubMed ID: 22680774
[TBL] [Abstract][Full Text] [Related]
19. Clinical outcome of patients with early stage favorable Hodgkin lymphoma treated with ABVD × two cycles followed by FDG-PET/CT restaging and 20 Gy of involved-site radiotherapy.
Kamran SC; Jacene HA; Chen YH; Mauch PM; Ng AK
Leuk Lymphoma; 2018 Jun; 59(6):1384-1390. PubMed ID: 28937297
[TBL] [Abstract][Full Text] [Related]
20. [Primary hodgkin lymphoma of thyroid: case report].
Hadri H; Fares S; Moutiqui T; Lembarki G; Moussali N; Benna NE; Regragui M; Bennani N; Naoumi S; Karkouri M; Quessar A
Pan Afr Med J; 2017; 28():266. PubMed ID: 29881509
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
